Peroxyvulgarin - Compound Card

Peroxyvulgarin

Select a section from the left sidebar

Peroxyvulgarin

Structure
Zoomed Structure
  • Family: Plantae - Asteraceae
  • Kingdom: Plantae
  • Class: Terpenoid
    • Subclass: Sesquiterpene Hydroperoxide
Canonical Smiles OO[C@@]1(C)C=CC(=O)[C@]2([C@H]1[C@H]1OC(=O)[C@H]([C@@H]1CC2)C)C
InChI InChI=1S/C15H20O5/c1-8-9-4-6-14(2)10(16)5-7-15(3,20-18)12(14)11(9)19-13(8)17/h5,7-9,11-12,18H,4,6H2,1-3H3/t8-,9-,11-,12+,14-,15-/m0/s1
InChIKey GPWOVUKAMABICF-DHKWMEDESA-N
Formula C15H20O5
HBA 5
HBD 1
MW 280.32
Rotatable Bonds 1
TPSA 72.83
LogP 1.97
Number Rings 3
Number Aromatic Rings 0
Heavy Atom Count 20
Formal Charge 0
Fraction CSP3 0.73
Exact Mass 280.13
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Artemisia abyssinica Asteraceae Plantae 2869510

Showing of synonyms

  • Al-Said MS, Khalifa SI, et al. (1989). Biogenetic-type synthesis of vulgarin and peroxyvulgarin.. Phytochemistry,1989,28(1),107-108. [View]
Pubchem: 162934240
Nmrshiftdb2: 70098210

No compound-protein relationship available.

Structure

SMILES: C1C(=O)OC(C12)C3C(CC2)C(=O)C=CC3

Level: 0

Mol. Weight: 280.32 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-4.63
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-4.470
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-2.19

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Penetrable
Fraction Unbound (Human)
0.500
Plasma Protein Binding
52.84
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
10.060
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Toxic
Bioconcentration Factor
0.130
Biodegradation
Safe
Carcinogenesis
Toxic
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.000
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
4.690
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-1.010
Rat (Acute)
2.800
Rat (Chronic Oral)
1.700
Fathead Minnow
3.890
Respiratory Disease
Safe
Skin Sensitisation
Toxic
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
342.010
Hydration Free Energy
-9.650
Log(D) at pH=7.4
0.580
Log(P)
0.6
Log S
-2.29
Log(Vapor Pressure)
-5.96
Melting Point
176.62
pKa Acid
8.59
pKa Basic
5.31

No predicted protein targets found for this compound.

Download SDF